Takeda Pharmaceutical’s new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027. It will initially be available through the private market for individuals. Takeda plans to pursue government procurement and National Immunisation Programme inclusion. This move significantly broadens Takeda’s public health focus in India.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.